Appearance
🎉 your ETH🥳
""
"Cellink is a biotechnology startup that designs bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Cellink was the first company to provide a standardized bio-ink product for sale over the internet. The company has ongoing collaborations with organizations including MedImmune, MIT and Takara Bio, and its printers are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. A stated goal of the company is to help address the existing global shortage of organs suitable for human transplantation. History Cellink was founded in 2016 by Erik Gatenholm, the company's chief executive, and Héctor Martinez. They developed and sold the world's first universally compatible bio-ink to simplify bioprinting for academics and pharmaceutical companies who were, at that time, mixing their own biomaterial in-house. The company released its first bioprinter to test the market in 2015, and continued designing additional bio-inks to support more specialized applications in bioprinting. Ten months after it was founded, Cellink was listed publicly on the Nasdaq exchange First North. At its IPO, shares were oversubscribed by 1070 percent. In 2017, the company was described as "a world leader in bioprinting". It established a United States headquarters in Boston the same year. The company's revenue totaled $4.88 million in 2018. As of February 2019, its products are used by more than 600 labs in more than 50 countries. Cellink acquired German biotechnology company Cytena in August 2019 for a purchase price of $33.8 million. Products The bio-ink produced by the company contains cellulose and alginate, locally sourced from trees in Sweden and seaweed from the Norwegian Sea, respectively. Cellink's bio-ink technology was developed at Chalmers University. , the company's bio-inks were priced in the range of US$9 and $299, while its bioprinters were priced in the US$10,000 to $40,000 range. An integral part of the company's customer service is to train customers at their sites and ensure that they can successfully use the technology. See also * Bioprinting References External links * Category:Emerging technologies Category:3D printer companies Category:Companies based in Massachusetts Category:Computer companies established in 2016 Category:Manufacturing companies of the United States Category:2016 establishments in Massachusetts Category:American companies established in 2016 Category:Swedish companies established in 2016 Category:Manufacturing companies established in 2016 "
"Erik Gatenholm is a Swedish-American entrepreneur. He is credited with creating the world's first universal bio-ink. Biography Gatenholm was raised mostly in Blacksburg, Virginia. He attended Blacksburg High School and studied Business Management at Virginia Tech University. He attended the Innovation and Industrial Management Master's program at the Gothenburg School of Business, Economics and Law, and received his Master's of Science in June 2016. Early work At age 18, Gatenholm started his first venture as a freshman at Virginia Tech. BC Genesis focused on developing surgical meshes for hernia repair and cartilage implants by commercializing Virginia Tech- owned intellectual property. Within three years of its founding, BC Genesis received two National Science Foundation grants for $600,000. The company also received a $700,000 grant from the Virginia Tobacco Indemnification and Community Revitalization Commission, and was slated to help revive Floyd County's economy through the introduction of more job opportunities in biotech. Gatenholm has had his own research published in line with his work. His abstract titled "Innovative bacterial nanocellulose medical devices: From incubator to human body" was published in 2013. Outside of the biotechnology sector, Gatenholm has also worked in music production. In 2014, Gatenholm wrote and produced "Finally" with vocalist Jalana. Gatenholm composed the track and played guitar for the recording, while Jalana contributed lyrics and vocals. The track was remixed several times, earning success across the electronic music scene and gaining radio airplay, chart positions and DJ support. Gatenholm was signed along with Jalana to Déepalma Records in 2015. Current work Gatenholm was introduced to 3D bioprinting in 2014. At that time, academics and pharmaceutical companies mixed their own bio-inks in- house, and Gatenholm recognized a gap in the market. He co-founded CELLINK in 2016 when he was 25 years old. CELLINK was listed on Nasdaq First North within ten months of its founding, and sales totaled $1 million in its first year. Awards * West Sweden's Young Entrepreneur of the Year, 2016. * Sweden's Young Entrepreneur of the Year, 2016. * Danske Bank's Innovator of the Year, 2016. * Swedbank's Future Award, 2016. * Anders Wall Award for Exceptional Entrepreneurship, 2017. * Forbes 30 Under 30, 2018. * Företagarna's Årets Företagare (Entrepreneurs of the Year), 2019. * MIT Technology Review magazine's Innovators Under 35 list of 2019. * Svenska Dagbladet's Affärsbragd (The Business Achievement) 2020 References Category:1989 births Category:21st-century American businesspeople Category:21st- century_Swedish_businesspeople Category:American technology company founders Category:Swedish technology company founders Category:American technology chief executives Category:Virginia Tech alumni Category:Living people "